Filing Flows

Filing Flows › Companies › Scienture Holdings › Cash flow

Scienture Holdings cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$3.1M in Q2 2026 · −$14.4M over twelve months

Operating cash flow−$3.1M
Free cash flow−$3.1M
Cash conversion cycle-10896 days

Analysis

In Q2 2026, Scienture Holdings generated −$3.1M of operating cash flow. That is $1.1M less than in Q2 2025 (−$2.0M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$14.4M; the largest uses were operating cash flow ($14.4M); besides operations, cash came from other financing ($25.6M); the cash balance rose by $11.2M.

Operating cash flow was −$3.1M against net income of −$2.8M. The largest differences: payables −$488K, depreciation & amortization +$462K, receivables +$337K.

Its cash conversion cycle was -10896 days (receivables 147 + inventory 2397 − payables 13439): suppliers fund its working capital.

Free cash flow

Scienture Holdings: free cash flow by quarterScienture Holdings: free cash flow by quarter−$5.4MQ3 2024−$2.9MQ4 2024−$3.0MQ1 2025−$2.0MQ2 2025−$3.2MQ3 2025−$5.2MQ4 2025−$2.9MQ1 2026−$3.1MQ2 2026
Operating cash flow less capital spending.
Scienture Holdings: operating cash flow against capital spendingScienture Holdings: operating cash flow against capital spendingOperating cash flowCapital spending−$5.4M$0Q3 2024−$2.9M$0Q4 2024−$3.0M$0Q1 2025−$2.0M$0Q2 2025−$3.2M$0Q3 2025−$5.2M$0Q4 2025−$2.9M$0Q1 2026−$3.1M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$3.1M, Capital spending $0.

Capital allocation, year by year

Scienture Holdings: where the cash came from (up) and went (down), by fiscal yearScienture Holdings: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsDividendsFY2021: Operating cash flow −$2.6MFY2021: Shares issued $2KFY2021: Capital spending −$23K$2KFY2021FY2022: Operating cash flow −$1.5MFY2022: Shares issued $131KFY2022: Asset sales $1K$132KFY2022FY2023: Operating cash flow −$2.2MFY2023: Net borrowing $250KFY2023: Acquisitions −$344K$250KFY2023FY2024: Operating cash flow −$14.3MFY2024: Shares issued $5.9MFY2024: Capital spending −$12KFY2024: Dividends −$14.9M$5.9MFY2024FY2025: Operating cash flow −$13.4MFY2025: Net borrowing −$5.7MFY2025: Shares issued $26.3M$26.3MFY2025
Over these 5 years operating cash flow totalled −$34.0M; the largest uses were operating cash flow ($34.0M) and dividends ($14.9M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$8.2M
Debt$2.0M
Net cash$6.2M
Cash runway7 months

Scienture Holdings is burning cash: its operations consume cash, a free cash flow of −$14.4M a year at the current rate against $8.2M of cash and investments: a runway of about 7 months before any new financing.

Where the cash came from and went

Scienture Holdings: sources (+) and uses (−) of cash, Q2 2026Scienture Holdings: sources (+) and uses (−) of cash, Q2 2026Other financing$10.8MCash drawn (+) / kept (−)−$7.7MOperating cash flow−$3.1M
Scienture Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Scienture Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$25.6MOperating cash flow−$14.4MCash drawn (+) / kept (−)−$11.2M

From profit to cash

Scienture Holdings: net income to operating cash flow, Q2 2026Scienture Holdings: net income to operating cash flow, Q2 2026Net income−$2.8MDepreciation & amortization$462KStock-based pay$103KReceivables$337KInventory$8KPayables−$488KAccrued liabilities−$200KPrepaid and other assets−$175KOperating cash flow−$3.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 2026147239713439-10896
Q1 20261162771551783-42906
Q3 202417112739-2711

Every quarter

QuarterOperating cash flowDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$3.1M———−$7.7M−$3.1M
Q1 2026−$2.9M———$3.1M−$2.9M
Q4 2025−$5.2M—−$5.9M$14.8M−$6.3M−$5.2M
Q3 2025−$3.2M—$1.6M$6.9M−$340K−$3.2M
Q2 2025−$2.0M———$2.0M−$2.0M
Q1 2025−$3.0M——$4.6M−$1.7M−$3.0M
Q4 2024−$2.9M———$119K−$2.9M
Q3 2024−$5.4M−$2.2M——$7.1M−$5.4M

Scienture Holdings: income statement and cash flow

Scienture Holdings, Q2 2026: revenue $344K, operating margin -785.6%. The chart follows the revenue to costs, profit and cash.

Scienture Holdings: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.